These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10536419

  • 1. [Macrophage-colony stimulating factor and ovarian cancer].
    Menditto A, Piscittelli V, Cassese F, Balbi GC, Balbi C, Cardone A.
    Minerva Ginecol; 1999; 51(7-8):261-4. PubMed ID: 10536419
    [Abstract] [Full Text] [Related]

  • 2. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer.
    Suzuki M, Ohwada M, Aida I, Tamada T, Hanamura T, Nagatomo M.
    Obstet Gynecol; 1993 Dec; 82(6):946-50. PubMed ID: 8233270
    [Abstract] [Full Text] [Related]

  • 3. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients].
    ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M, Tamura N, Kobayashi H, Ohwada M, Terao T, Sato I.
    Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
    [Abstract] [Full Text] [Related]

  • 5. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M.
    Clin Chim Acta; 2007 May 01; 380(1-2):208-12. PubMed ID: 17368603
    [Abstract] [Full Text] [Related]

  • 6. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S, Szmitkowski M, Wojtukiewicz M.
    Clin Chim Acta; 2006 Sep 01; 371(1-2):112-6. PubMed ID: 16631152
    [Abstract] [Full Text] [Related]

  • 7. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
    Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW.
    Clin Cancer Res; 1995 Mar 01; 1(3):313-25. PubMed ID: 9815987
    [Abstract] [Full Text] [Related]

  • 8. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary.
    Suzuki M, Kobayashi H, Ohwada M, Terao T, Sato I.
    Gynecol Oncol; 1998 Jan 01; 68(1):35-7. PubMed ID: 9454657
    [Abstract] [Full Text] [Related]

  • 9. Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Castellani C, Annicchiarico C, Prontera C, Facchini V, Bianchi R, Genazzani AR.
    Gynecol Oncol; 1998 Jul 01; 70(1):111-4. PubMed ID: 9698485
    [Abstract] [Full Text] [Related]

  • 10. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients].
    Lawicki S, Bedkowska E, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2008 Jul 01; 25(145):38-42. PubMed ID: 18839612
    [Abstract] [Full Text] [Related]

  • 11. [Selected hematopoietic cytokines in patients with colorectal cancer].
    Mroczko B, Ławicki S, Szmitkowski M, Czygier M, Okulczyk B, Piotrowski Z.
    Pol Merkur Lekarski; 2003 Nov 01; 15(89):416-9. PubMed ID: 14969133
    [Abstract] [Full Text] [Related]

  • 12. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M.
    Pol Merkur Lekarski; 2007 Oct 01; 23(136):259-63. PubMed ID: 18293847
    [Abstract] [Full Text] [Related]

  • 13. B7-H4 overexpression in ovarian tumors.
    Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR.
    Gynecol Oncol; 2006 Jan 01; 100(1):44-52. PubMed ID: 16256178
    [Abstract] [Full Text] [Related]

  • 14. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors].
    Li L, Wang LM, Zhang W, Zhang JQ, Song HL, Yao DS, Tang Y, Chen XQ, Yang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb 01; 38(2):72-6. PubMed ID: 12783691
    [Abstract] [Full Text] [Related]

  • 15. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M, Arsenijević S, Lukić G, Arsenijević N, Ristić P, Pavlović S, Popović S, Baskić D.
    J BUON; 2007 Feb 01; 12(1):99-104. PubMed ID: 17436409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical usefulness of macrophage colony-stimulating factor for ovarian cancers: Long-term prognosis after five years.
    Mizutani K, Takeuchi S, Ohashi Y, Yakushiji M, Nishimura H, Takahashi T, Maruhashi T, Ueda K, Noda K, Watanabe Y, Kawana T, Terashima Y, Ochiai K, Goto S, Takaku F, Motoyoshi K.
    Oncol Rep; 2003 Feb 01; 10(1):127-31. PubMed ID: 12469157
    [Abstract] [Full Text] [Related]

  • 20. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX, Wu Y, Han HQ, Wang QH.
    Ai Zheng; 2003 Jan 01; 22(1):58-61. PubMed ID: 12561438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.